Women implanted with cardiac implantable electronic devices (CIEDs) like pacemakers, implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy (CRT) technologies are more likely to experience acute CIED…

Medtronic announced on Jan. 15 the launch of a mobile app that connects four of the company’s pacemakers to patients’ smartphones and…

Men who are dissatisfied with their marriages are around 86 percent more likely to experience sudden cardiac death (SCD) than those who are very satisfied, according to research published in the Jan. 1 edition of the…

A high-density electroanatomic mapping study of 75 patients with atrial fibrillation (AF) has concluded that even a regular alcohol intake—up to 14 standard drinks per week—is associated with impairments in electrical signaling and more…

AI applied to an electrocardiogram (EKG) test reliably detected asymptomatic left ventricular dysfunction (ALVD)—a precursor to heart failure—and predicted which patients were most at risk of developing the condition in the future,…

A side-by-side comparison of electronic and analog stethoscopes suggests a digital approach to auscultation is indeed superior to its predecessors, debunking the idea that electronic models might suffer from sound cutoffs and contact…

Chronic exposure to secondhand smoke in common settings like cars, homes and casinos may increase a person’s susceptibility to cardiac alternans, a precursor to ventricular arrhythmias, according to an animal study published in…

Experts Outline Device Selection, Prophylactic Antibiotics, Pre-procedural Protocols & Post-implementation Vigilance 

Cardiac implantable electronic devices (CIEDs) have been heralded as a major advance in patient…

Compared to drug therapy alone, catheter ablation nearly halved the risk of death and improved a range of clinical outcomes for patients with both heart failure and atrial fibrillation (AFib) in a meta-analysis.

…

About 1 in 6 patients with newly diagnosed atrial fibrillation (AFib) who are considered at low risk of stroke advance to a higher risk category within one year, according to a…

The FDA has granted premarket approval to Cardiva Medical’s vascular closure system for use during electrophysiology procedures such as cardiac ablation and left atrial appendage closure, the company announced Dec. 18.

…

U.K.-based startup Cambridge Heartware has announced the launch of its company and its first product, a wearable heart monitor powered by artificial intelligence, in early 2019.

CEO Rameen Shakur, MD, PhD, also a…

A trial designed to test the effectiveness of additional antibiotic prophylaxis before and after cardiac electronic device implantation found that such an approach did not significantly lower the rate of subsequent infections, although…

It takes emergency medical services (EMS) almost four minutes longer to transport cardiac arrest patients from poor neighborhoods to the hospital versus those from high-income neighborhoods, according to a…

Atrial fibrillation could be an independent predictor of worse outcomes in heart patients with implantable cardioverter-defibrillators (ICDs), according to a meta-analysis published this November in the…

Regardless of clinical and socioeconomic factors, black patients with atrial fibrillation (AF) are significantly less likely than whites and Hispanics to receive appropriate treatment with oral anticoagulants (OACs), researchers…

People who experience out-of-hospital cardiac arrest (OHCA) are nearly twice as likely to survive if they are transferred directly to a hospital with 24-hour capability to perform PCI or targeted temperature management (TTM) versus another…

When consumers think of wearable personal health devices, they likely picture smartwatches or other wrist-worn gadgets. But as Forbes pointed out in a Nov. 26 article, new headphone-type wearables—dubbed “hearables”—have already grown into…

Almost 1 in 5 patients are rehospitalized within 30 days of undergoing catheter ablation of MI-associated ventricular tachycardia (VT), according to a study from the Nationwide Readmissions Database. These patients rack up 38.9 percent…

Monitoring digoxin concentration and platelet activation in atrial fibrillation (AF) patients treated with vitamin K antagonists could be important for reducing those patients’ inherently elevated risk for CVD, according to a…

Half a decade of planning and millions of dollars have culminated in the Alliance for Cardiovascular Diagnostic and Treatment Innovation (ADVANCE), a joint engineering and cardiology center launched by Johns Hopkins University in an…